about
Evolutionary Ecology of Organs: A Missing Link in Cancer Development?Cancer Evolution and the Limits of Predictability in Precision Cancer MedicineIntergenically Spliced Chimeric RNAs in Cancer.Modeling Tumor Clonal Evolution for Drug Combinations DesignCRISPR/Cas9: From Genome Engineering to Cancer Drug DiscoveryActionable molecular biomarkers in primary brain tumors.Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges.Collateral Lethality: A new therapeutic strategy in oncologyImmune response to cancer therapy: mounting an effective antitumor response and mechanisms of resistanceThe Microbiome and Cancer: Is the 'Oncobiome' Mirage Real?Why does infection with some helminths cause cancer?Micronutrients: A double-edged sword in microbial-induced gastric carcinogenesis.Targeting Transcription Factors in CancerThe Emerging Role of ABL Kinases in Solid Tumors.Long noncoding RNAs in cancer: from function to translation.Developmental Insights into Breast Cancer Intratumoral Heterogeneity.The journey of DNA repairAnti-CD73 in cancer immunotherapy: awakening new opportunities.The Impact of DNA Methylation in Hematopoietic Malignancies.Glioblastoma: Defining Tumor Niches.Modeling pancreatic cancer with organoidsHuman papillomaviruses: research priorities for the next decade.Radiotherapy: Changing the Game in Immunotherapy.Resisting Resistance: Targeted Therapies in Lung Cancer.The Hidden Conundrum of Phosphoinositide Signaling in CancerOncogene-directed alterations in cancer cell metabolism.Targeting RAS-mutant cancers: is ERK the key?Microfluidics: A new tool for modeling cancer-immune interactions.Cancer Nanomedicine: Lessons for Immuno-Oncology.Biomarkers in Melanoma: Lessons from Translational Medicine.Cancer Prevention: Lessons Learned and Future Directions.Filling the Gap on Caveolin-1 in Liver Carcinogenesis.The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic Lethality.Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation.Autoantibodies: Opportunities for Early Cancer Detection.NLRC5/CITA: A Key Player in Cancer Immune Surveillance.Exercise and the Hallmarks of Cancer.Metronomic Chemotherapy: Direct Targeting of Cancer Cells after all?RNA-Binding Proteins in Cancer: Old Players and New Actors.Intravital Insights into Heterogeneity, Metastasis, and Therapy Responses.
P1433
Q26261170-B410EB22-C084-480C-AE8A-833115349BF8Q26767415-F8B0FE79-840C-4AA0-9FA0-7D1C06A7E0F8Q30274742-0E5B2702-AB62-4B22-830B-9222BA191652Q33590430-807A3846-624A-4D10-93BD-93113421E2EBQ33772342-59B3D6B2-B5D3-49B9-8017-A7BEBE6A054CQ33772355-685DFD22-56C2-492E-8469-06B643B719E6Q33828559-CEDFABF9-E161-4FC1-B02E-C944F8A27B4FQ34513800-6B57B5E6-87A1-4456-8FCF-1F8E31EFD152Q36125878-AED7D56E-F598-42F6-A40F-FA4163FF6408Q36272668-027A0541-5247-43E7-99D1-650516E497A0Q36310498-F4920F8A-5F96-44EF-B633-C5A7F87F1D00Q36326147-4D622175-1EAC-4865-88D5-B121C76847BBQ36347511-E91E7304-2B5F-491A-A9FC-6F80E828C4C8Q36347666-4466307D-23CF-4B1B-A378-A89679B16405Q36353705-37129251-A45D-4A62-AA5C-2B2CE9B3D027Q36438839-B6CAD0AF-EBDA-44C3-AFEA-442FEC2D68F4Q36549482-501E2697-D5AC-4181-B760-F0227325FC30Q36709157-DA81F6F1-F415-417C-ACE0-5BEFACE198C3Q36724810-59C01503-D367-4A76-BE67-6099B7E80C21Q36796616-FE512AC3-EEB2-477F-A661-9BD21748602CQ36842030-1040444E-02BD-44E3-9CFE-3C17CDA0C238Q37241711-E554B2A1-7B92-4932-8B22-13B0F9B4B238Q37351338-7294F5F8-F7D2-4520-B138-1D56B2561512Q37388238-5727368B-3408-4CF4-921D-FEC4D9582E65Q37391319-DB34CAAD-E0F7-4434-ACD0-8BC4EBD55594Q37395416-416140CD-6E96-4A00-A9D0-63FAA03A1F20Q38267209-6B4F5ED8-795E-4CB5-80F0-C37948E967FBQ38269600-16F2F0CA-4D77-4192-8339-E8F845285C07Q38646361-9F8E29A6-A7F5-4A04-8374-5BE753331486Q38652178-04F172FA-C693-445A-9EF2-0D2BC6161BBCQ38652183-F1107335-F904-4BA2-910F-4EEBDDEFD913Q38652187-80845A92-CB57-428B-A940-B81A15641812Q38652190-D684BF1F-47B2-42E3-B1ED-533D9E163CBCQ38652194-3BC68640-803F-4E35-89A1-A6A15EF118C2Q38656064-CF43A6D2-6BA9-4978-BA25-7C14AC85CCA8Q38656067-C006BAEB-E836-4172-80F4-E669D222275CQ38656072-A4A8346D-F407-4E7E-9F1D-1A4B1156F6D3Q38656076-82BA908B-B4F0-48D3-A45B-124F5BDFC2CBQ38656079-13CF0C7C-C254-4402-B63A-CF95A56DB69AQ38662882-4A0BF050-6092-43A5-A571-DEFDE4F88A82
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
Trends in cancer
@ast
Trends in cancer
@en
Trends in cancer
@es
Trends in cancer
@nl
type
label
Trends in cancer
@ast
Trends in cancer
@en
Trends in cancer
@es
Trends in cancer
@nl
altLabel
Trends Cancer
@en
prefLabel
Trends in cancer
@ast
Trends in cancer
@en
Trends in cancer
@es
Trends in cancer
@nl
P3181
P1055
P1156
21100445640
P123
P1277
P1476
Trends in cancer
@en
P236
P3181
P5963
trends-in-cancer